-
Company Insights
NewPhonePe – Competitor Profile
PhonePe is one of the most widely adopted mobile wallets in India, with over 520 million users. The company was founded as a fintech startup in late 2015; by April 2016, PhonePe was operating as a subsidiary of ecommerce platform Flipkart. With heavy financial backing from Flipkart, the mobile wallet service flourished. In 2020, US retail giant Walmart (the owner of Flipkart) decided to spin off PhonePe to operate as a separate entity (a process that was completed in December...
-
Company Insights
NewM-PESA – Competitor Profile
M-PESA is a mobile-based fund transfer and micro-level banking service available to customers of Safaricom, Kenya’s largest mobile network. Introduced in 2007, the service has become a primary channel for fund transfers in the country. Originally developed as a low-cost microfinance loan repayment system, it was extended as an open platform to remit funds and make consumer payments due to its rising popularity. This was largely a result of factors such as the high cost of remitting funds through banks,...
-
Sector Analysis
NewEurope Fibercos and Towercos Market Dynamics and Opportunities
Europe Fibercos and Towercos Market Report Overview Fibercos and towercos in Europe are heading toward organic growth strategies for controlling debts and sustaining rollout targets. Furthermore, infrastructure companies are trying to reduce their carbon emissions by generating power to support their operations. Large consumer base and favorable regulatory environment in Europe have made the region the most viable choice for investments from international telecommunications players. Additionally, a surge in demand for high-speed connectivity in the European economies is encouraging telecom...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povetacicept in Lupus Nephritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povetacicept in Lupus Nephritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povetacicept in Lupus Nephritis Drug Details: Povetacicept is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povetacicept in Membranous Glomerulonephritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povetacicept in Membranous Glomerulonephritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povetacicept in Membranous Glomerulonephritis Drug Details: Povetacicept is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povetacicept in IgA Nephropathy (Berger’s Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povetacicept in IgA Nephropathy (Berger's Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povetacicept in IgA Nephropathy (Berger's Disease) Drug Details: Povetacicept...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povetacicept in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povetacicept in Systemic Lupus Erythematosus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povetacicept in Systemic Lupus Erythematosus Drug Details: Povetacicept is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povetacicept in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povetacicept in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povetacicept in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic...
-
Analyst Opinions
Middle East Energy Transition Market Trends and Analysis by Power and Renewables, Electrical Vehicles, Hydrogen and CCS/CCU, 2024 Update
Middle East Energy Transition Market Overview The presence of massive oil and gas reserves and the low cost of production make traditional fossil fuels the dominant source of power generation in the Middle East. However, the energy transition in the region is slow yet steady. The ‘Middle East Energy Transition Market Report’ analyzes the region’s energy transition to renewable energy sources from a fossil fuel-dominated market into a sustainable energy-producing region. Key Sectors ·      Renewable Energy ·      Electric Vehicles ·      ...